Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Crigler-Najjar Syndrome Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Crigler-Najjar Syndrome Drugmarket, defines the market attractiveness level of Crigler-Najjar Syndrome Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Crigler-Najjar Syndrome Drug industry, describes the types of Crigler-Najjar Syndrome Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Crigler-Najjar Syndrome Drug market and the development prospects and opportunities of Crigler-Najjar Syndrome Drug industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Crigler-Najjar Syndrome Drug market in Chapter 13.
By Player:
Audentes Therapeutics Inc
Genethon SA
International Stem Cell Corp
Promethera Biosciences SA
By Type:
ALXN-1540
AT-342
HepaStem
Others
By End-User:
Hospital
Clinic
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Crigler-Najjar Syndrome Drug Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Crigler-Najjar Syndrome Drug Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Crigler-Najjar Syndrome Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Crigler-Najjar Syndrome Drug Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Crigler-Najjar Syndrome Drug Market Analysis and Outlook to 2022
-
7.1 Global Crigler-Najjar Syndrome Drug Consumption (2017-2022)
-
7.2 United States Crigler-Najjar Syndrome Drug Consumption (2017-2022)
-
7.3 Europe Crigler-Najjar Syndrome Drug Consumption (2017-2022)
-
7.4 China Crigler-Najjar Syndrome Drug Consumption (2017-2022)
-
7.5 Japan Crigler-Najjar Syndrome Drug Consumption (2017-2022)
-
7.6 India Crigler-Najjar Syndrome Drug Consumption (2017-2022)
-
7.7 South Korea Crigler-Najjar Syndrome Drug Consumption (2017-2022)
8 Region and Country-wise Crigler-Najjar Syndrome Drug Market Analysis and Outlook to 2028
-
8.1 Global Crigler-Najjar Syndrome Drug Consumption Forecast (2022-2028)
-
8.2 United States Crigler-Najjar Syndrome Drug Consumption Forecast (2022-2028)
-
8.3 Europe Crigler-Najjar Syndrome Drug Consumption Forecast (2022-2028)
-
8.4 China Crigler-Najjar Syndrome Drug Consumption Forecast (2022-2028)
-
8.5 Japan Crigler-Najjar Syndrome Drug Consumption Forecast (2022-2028)
-
8.6 India Crigler-Najjar Syndrome Drug Consumption Forecast (2022-2028)
-
8.7 South Korea Crigler-Najjar Syndrome Drug Consumption Forecast (2022-2028)
9 Global Crigler-Najjar Syndrome Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Crigler-Najjar Syndrome Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global ALXN-1540 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global AT-342 Consumption and Growth Rate (2017-2022)
-
9.1.3 Global HepaStem Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Crigler-Najjar Syndrome Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Crigler-Najjar Syndrome Drug Market Outlook by Types and Applications to 2028
-
10.1 Global Crigler-Najjar Syndrome Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global ALXN-1540 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global AT-342 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global HepaStem Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Crigler-Najjar Syndrome Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Crigler-Najjar Syndrome Drug Import and Export Analysis (Top 5 Countries)
-
11.1 Global Crigler-Najjar Syndrome Drug Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Crigler-Najjar Syndrome Drug Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Crigler-Najjar Syndrome Drug Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Crigler-Najjar Syndrome Drug Market Competitive Analysis
-
14.1 Audentes Therapeutics Inc
-
14.1.1 Audentes Therapeutics Inc Company Details
-
14.1.2 Audentes Therapeutics Inc Crigler-Najjar Syndrome Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Audentes Therapeutics Inc Crigler-Najjar Syndrome Drug Product and Service
-
14.2 Genethon SA
-
14.2.1 Genethon SA Company Details
-
14.2.2 Genethon SA Crigler-Najjar Syndrome Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Genethon SA Crigler-Najjar Syndrome Drug Product and Service
-
14.3 International Stem Cell Corp
-
14.3.1 International Stem Cell Corp Company Details
-
14.3.2 International Stem Cell Corp Crigler-Najjar Syndrome Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 International Stem Cell Corp Crigler-Najjar Syndrome Drug Product and Service
-
14.4 Promethera Biosciences SA
-
14.4.1 Promethera Biosciences SA Company Details
-
14.4.2 Promethera Biosciences SA Crigler-Najjar Syndrome Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Promethera Biosciences SA Crigler-Najjar Syndrome Drug Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Crigler-Najjar Syndrome Drug
-
Figure Crigler-Najjar Syndrome Drug Picture
-
Table Global Crigler-Najjar Syndrome Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Crigler-Najjar Syndrome Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Crigler-Najjar Syndrome Drug Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Crigler-Najjar Syndrome Drug Consumption by Country (2017-2022)
-
Figure United States Crigler-Najjar Syndrome Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Crigler-Najjar Syndrome Drug Consumption and Growth Rate (2017-2022)
-
Figure China Crigler-Najjar Syndrome Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Crigler-Najjar Syndrome Drug Consumption and Growth Rate (2017-2022)
-
Figure India Crigler-Najjar Syndrome Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Crigler-Najjar Syndrome Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Crigler-Najjar Syndrome Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Crigler-Najjar Syndrome Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Crigler-Najjar Syndrome Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Crigler-Najjar Syndrome Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Crigler-Najjar Syndrome Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Crigler-Najjar Syndrome Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Crigler-Najjar Syndrome Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global ALXN-1540 Consumption and Growth Rate (2017-2022)
-
Figure Global AT-342 Consumption and Growth Rate (2017-2022)
-
Figure Global HepaStem Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global ALXN-1540 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global AT-342 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global HepaStem Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Crigler-Najjar Syndrome Drug Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Crigler-Najjar Syndrome Drug Export by Region (Top 5 Countries) (2017-2028)
-
Table Audentes Therapeutics Inc (Foundation Year, Company Profile and etc.)
-
Table Audentes Therapeutics Inc Crigler-Najjar Syndrome Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Audentes Therapeutics Inc Crigler-Najjar Syndrome Drug Product and Service
-
Table Genethon SA (Foundation Year, Company Profile and etc.)
-
Table Genethon SA Crigler-Najjar Syndrome Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genethon SA Crigler-Najjar Syndrome Drug Product and Service
-
Table International Stem Cell Corp (Foundation Year, Company Profile and etc.)
-
Table International Stem Cell Corp Crigler-Najjar Syndrome Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table International Stem Cell Corp Crigler-Najjar Syndrome Drug Product and Service
-
Table Promethera Biosciences SA (Foundation Year, Company Profile and etc.)
-
Table Promethera Biosciences SA Crigler-Najjar Syndrome Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Promethera Biosciences SA Crigler-Najjar Syndrome Drug Product and Service
-
